Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biologicals : Journal of the International Association of Biological Standardization|July 5, 2022
Study on an attenuated rabies virus strain CTN181-3Leitai Shi, Jian Zou, Yuhua Li, et al.
Vaccines|February 26, 2025
Novel Standard Substance from Primary Hamster Kidney Cells for Quality Control of Human Rabies Vaccines in ChinaLeitai Shi, Jia Li, Xiaohong Wu, et al.
Frontiers in Microbiology|June 1, 2026
Development and validation of a Vero cell DNA standard for residual DNA measurement suitable for quantitative PCR methodDanhua Zhao, Yunpeng Wang, Xiaohong Wu, et al.
Human Vaccines & Immunotherapeutics|January 8, 2013
Development of a Vero cell DNA reference standard for residual DNA measurement in ChinaShouchun Cao, Guanmu Dong, Jianrong Tang, et al.
Human Vaccines & Immunotherapeutics|November 13, 2024
Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimesJia Li, Zhiang Wu, Xiaohong Wu, et al.
Vaccines|November 26, 2024
Immunogenicity Persistence of Different Immunization Regimens of Rabies Vaccine in the 10-60 Years Age Group: A Follow-Up Report Based on Phase III Clinical TrialYunpeng Wang, Zhiang Wu, Jia Li, et al.
Human Vaccines & Immunotherapeutics|November 21, 2018
Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trialXingyu Zhou, Xiaohong Wu, Yong Cai, et al.
Vaccine|April 6, 2025
Safety, immunogenicity and immune persistence of a lyophilized purified human diploid cells rabies vaccine following rabies PEP regimen Essen and Zagreb: A randomized, blinded controlled phase 3 trial in healthy participants aged 10-60 years oldGuifan Li, Shouchun Cao, Bidan Xu, et al.
Vaccines|January 8, 2025
Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies VaccineJia Li, Ruowen Pan, Fengyi Yue, et al.
Medcomm|January 6, 2025
A SARS-CoV-2 EG.5 mRNA vaccine induces a broad-spectrum immune response in miceHongyu Wang, Qinhua Peng, Xinxian Dai, et al.
Pageof 2